SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-041752
Filing Date
2023-11-17
Accepted
2023-11-17 06:02:22
Documents
5
Period of Report
2023-11-17

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 380126
2 formdef14a_001.jpg GRAPHIC 2475
3 formdef14a_002.jpg GRAPHIC 6228
4 formdef14a_003.jpg GRAPHIC 7569
5 formdef14a_004.jpg GRAPHIC 11861
  Complete submission text file 0001493152-23-041752.txt   420399
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40943 | Film No.: 231416340
SIC: 2834 Pharmaceutical Preparations